Leyva-Huerta ER, Ledesma-Montes
C, Rojo-Botello RE, Vega-Memije
E. P53 and bcl-2 immunoexpression in patients
with oral lichen planus and oral squamous cell
carcinoma. Med Oral Patol Oral Cir Bucal. 2012 Sep 1;17
(5):e745-50.
doi:10.4317/medoral.18013
1. Torrente-Castells E, Figueiredo R, Berini-Aytés L,
Gay-Escoda C. Clinical features of oral lichen planus. A retrospective study of 65
cases. Med Oral Patol Oral
Cir Bucal. 2010;15:e685-90.
http://dx.doi.org/10.4317/medoral.15.e685
2. van der
Meij EH, Mast H, van der
Waal I. The possible premalignant character of oral lichen planus
and oral lichenoid lesions: A prospective five-year
follow-up study of 192 patients. Oral Oncol.
2007;43:742-8.
http://dx.doi.org/10.1016/j.oraloncology.2006.09.006
PMid:17112770
3. Ingafou M, Leao JC,
Porter SR, Scully C. Oral lichen planus: a
retrospective study of 690 British patients. Oral Dis. 2006;12:463-8.
http://dx.doi.org/10.1111/j.1601-0825.2005.01221.x
PMid:16910916
4. Hsue
SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM. Malignant transformation
in 1458 patients with potentially malignant oral mucosal disorders: a follow-up
study based in a Taiwanese hospital. J Oral Pathol
Med. 2007;36:25-9.
http://dx.doi.org/10.1111/j.1600-0714.2006.00491.x
5. Johnson N, Franceschi S, Ferlay J, Ramadas K, Schmid S, McDonald DG, et al. Squamous
cell carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D. WHO Classification of Tumours. Pathology and Genetics. Head and Neck Tumours. Lyon; IARC Press: 2005.p.168-175.
6. Hussein MR, Al-Badaiwy ZH, Guirguis
MN. Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pre-tumorigenic and tumorigenic keratinocytic hyperproliferative lesions. J Cutan Pathol. 2004;31:643-51.
http://dx.doi.org/10.1111/j.0303-6987.2004.00244.x
PMid:15491323
7. Warnakulasuriya KA, Johnson NW. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant
oral lesions. J Oral Pathol Med. 1992;21:404-8.
http://dx.doi.org/10.1111/j.1600-0714.1992.tb01028.x
PMid:1432735
8. Schoelch ML, Le QT, Silverman S Jr, McMillan A, Dekker NP, Fu KK, et al.
Apoptosis-associated proteins and the development of oral squamous
cell carcinoma. Oral Oncol. 1999;35:77-85.
http://dx.doi.org/10.1016/S1368-8375(98)00065-7
9. Gonzalez-Moles MA, Galindo P, Gutierrez-Fernandez
J, Sanchez-Fernandez E, Rodriguez-Archilla
A, Ruiz-Avila I, et al. P53
protein expression in oral squamous cell carcinoma. Survival analysis. Anticancer Res. 2001;21:2889-94.
PMid:11712782
10. Dekker NP, Lozada-Nur F, Lagenaur LA, McPhail LA, Bloom
CY, Regezi JA. Apoptosis-associated
markers in oral lichen planus. J Oral Pathol Med. 1997;26:170-5.
http://dx.doi.org/10.1111/j.1600-0714.1997.tb00453.x
PMid:9176791
11. Tanda N, Mori S, Saito K, Sakamoto S. Expression
of apoptotic signaling proteins in leukoplakia and
oral lichen planus: quantitative and topographical
studies. J Oral Pathol Med. 2000;29:385-93.
http://dx.doi.org/10.1034/j.1600-0714.2000.290804.x
PMid:10972347
12. Neppelberg E, Johannessen AC, Jonsson
R. Apoptosis in oral lichen planus. J Oral
Sci. 2001;109:361-4.
http://dx.doi.org/10.1034/j.1600-0722.2001.00081.x
PMid:11695759
13. Nakagawa K, Yamamura K, Maeda S, Ichihashi M. bcl-2
expression in epidermal keratinocytic diseases. Cancer. 1994;74:1720-4.
http://dx.doi.org/10.1002/1097-0142(19940915)74:6<1720::AID-CNCR2820740613>3.0.CO;2-T
14. Bascones C, González-Moles MA, Esparza G, Bravo
M, Acevedo A, Gil-Montoya JA, et al. Apoptosis and cell cycle
arrest in oral lichen planus. Hypothesis
on their possible influence on its malignant transformation. Arch Oral
Biol. 2005;50:873-81.
http://dx.doi.org/10.1016/j.archoralbio.2005.02.005
PMid:16137496
15. González-Moles MA, Bascones-Ilundain
C, Gil-Montoya JA, Ruiz-Ávila I, Delgado-Rodríguez M, Bascones-Martínez A.
Cell cycle regulating mechanisms in oral lichen planus:
molecular bases in epithelium predisposed to malignant transformation. Arch
Oral Biol. 2006;51:1093-103.
http://dx.doi.org/10.1016/j.archoralbio.2006.06.007
PMid:16914114
16. Schifter M, Jones AM, Walker DM. Epithelial p53
gene expression and mutational analysis, combined with growth fraction
assessment, in oral lichen planus. J Oral Pathol Med. 1998;27:318-24.
http://dx.doi.org/10.1111/j.1600-0714.1998.tb01963.x
17. Hirota M, Ito T, Okudela K, Kawabe R, Yazawa T, Hayashi H, et al. Cell proliferation activity in
the expression of cell cycle regulatory proteins in oral lichen planus. J Oral Pathol Med. 2002;31:204-12.
http://dx.doi.org/10.1034/j.1600-0714.2002.310403.x
PMid:12076323
18. González-Moles MA, Gil-Montoya JA, Ruiz-Ávila I,
Esteban F, Bascones-Martínez A. Differences in the
expression of p53 protein in oral lichen planus based
on the use of monoclonal antibodies DO7 and pAB 240. Oral Oncol. 2008;44:496-503.
http://dx.doi.org/10.1016/j.oraloncology.2007.06.013
PMid:17826304
19. Lee JJ, Kuo MY, Cheng SJ, Chiang CP, Jeng JH, Chang HH, et al. Higher expression of p53 and
proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:471-8.
http://dx.doi.org/10.1016/j.tripleo.2004.10.018
PMid:15772596
20. Valente G, Pagano M, Carrozzo M, Carbone M, Bobba V, Palestro G, et al. Sequential immunohistochemical
p53 expression in biopsies of oral lichen planus
undergoing malignant evolution. J Oral Pathol
Med. 2001;30:135-40.
http://dx.doi.org/10.1034/j.1600-0714.2001.300302.x
PMid:11271627
21. Ogden G, Kiddie RA, Lunny DP, Lane DP. Assessment of
p53 protein expression in normal, benign and malignant oral mucosa. J Pathol. 1992;166:389-94.
http://dx.doi.org/10.1002/path.1711660411
PMid:1381431
22. Kannan K, Latha PN, Shanmugam G. Expression of bcl-2 oncoprotein
in Indian oral squamous cell carcinomas. Oral Oncol. 1998;34:373-6.
http://dx.doi.org/10.1016/S1368-8375(98)00037-2
23. Loro LL, Vintermyr OK, Johanessen AC. Cell
death regulation in oral squamous cell carcinoma:
methodological considerations and clinical significance. J Oral Pathol Med. 2003;32:125-8.
http://dx.doi.org/10.1034/j.1600-0714.2003.00052.x
PMid:12581382
24. Loro LL, Johannessen
AC, Vintermyr OK. Decreased
expression of bcl-2 in moderate and severe oral epithelia dysplasias.
Oral Oncol. 2002;38:691-8.
http://dx.doi.org/10.1016/S1368-8375(02)00002-7
25. Jordan RC, Catzavelos GC,
Barrett AW, Speight PM. Differential expression of bcl-2 and bax in squamous cell carcinomas
of the oral cavity. Eur J Cancer B Oral Oncol. 1996;32B:394-400.
http://dx.doi.org/10.1016/S0964-1955(96)00033-4
26. Kramer IR, Lucas RB, Pindborg
JJ, Sobin LH. Definition of leukoplakia
and related lesions: an aid to studies on oral precancer.
Oral Surg Oral Med Oral Pathol. 1978;46:518-39.
http://dx.doi.org/10.1016/0030-4220(78)90383-3
27. Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, et al. Oral lichen planus
and oral lichenoid lesions: diagnostic and
therapeutic considerations. Oral Surg
Oral Med Oral Pathol Oral Radiol
Endod. 2007;103
Suppl:S25.e1-12.
28. Miyashita T, Krajewski S, Krajewska
M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor p53 is a regulator
of bcl-2 and bax expression in vitro and in vivo. Oncogene. 1994;9:1799-805.
PMid:8183579
29. González-Moles MA, Mosqueda-Taylor A, Delgado-Rodríguez M, Martínez-Mata G,
Gil-Montoya JA, Díaz-Franco MA, et al. Analysis
of p53 protein and Pab240, Ki-67 expression and human papilloma
virus DNA detection in different types of odontogenic
keratocysts. Anticancer
Res. 2006;26:175-81.
PMid:16475695
30. Bascones-Ilundain C, González-Moles
MA, Esparza G, Gil-Montoya JA, Bascones-Martínez A.
Significance of liquefaction degeneration in oral lichen planus:
a study of its relationship with apoptosis and cell cycle arrest markers. Clin Exp Dermatol. 2007;32:556-63.
http://dx.doi.org/10.1111/j.1365-2230.2007.02457.x
PMid:17608758